Determining Exercise Tolerance using an EMG Cycle Test in patients with FSHD

Completed

• Conditions: Facioscapulohumeral Muscular Dystrophy; Landouzy Dejerine; 10028396

• Registration Number: NL-OMON44203
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 18

Inclusion Criteria

- aged 18 years and older
- being able to read and understand the Dutch language
- mentally competent
- being able to cycle at least 8 minutes on a bicycle ergometer

Exclusion Criteria

- pregnancy
- cognitive impairment
- disabling co-morbidity interfering with the cycle test
- contraindications to Exercise Stress Testing according to the guidelines of the American Heart Association

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>sEMG amplitude<br /><br>sEMG median frequency</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>gas variables (spirometry)<br /><br>lactate, workload, heart rate<br /><br>ECG<br /><br>blood lactate levels<br /><br>blood pressure<br /><br>saturation<br /><br>Borg scale</p><br>